(Q34810301)

4 August 2017

1 reference

title

Antibodies, viruses and vaccines (English)

1 reference

4 August 2017

1 reference

1

Dennis R Burton

1 reference

PubMed ID

12209139

4 August 2017

language of work or name

1 reference

1 September 2002

1 reference

Nature Reviews Immunology

4 August 2017

1 reference

4 August 2017

2

1 reference

4 August 2017

706-713

1 reference

4 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/nri891

4 August 2017

0 references

cites work

Maternal antibodies, childhood infections, and autoimmune diseases

1 reference

Neutralizing antiviral antibody responses

31 March 2020

1 reference

Human trials of AIDS vaccines: current status and future directions

31 March 2020

1 reference

AIDS research. Merck reemerges with a bold AIDS vaccine effort

31 March 2020

1 reference

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

31 March 2020

1 reference

New hope for an AIDS vaccine

31 March 2020

1 reference

Prospects for vaccine protection against HIV-1 infection and AIDS.

31 March 2020

1 reference

The antiviral activity of antibodies in vitro and in vivo.

31 March 2020

1 reference

Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell

31 March 2020

1 reference

Antibody-mediated clearance of alphavirus infection from neurons

31 March 2020

1 reference

Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission

31 March 2020

1 reference

Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro

31 March 2020

1 reference

Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1

31 March 2020

1 reference

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

31 March 2020

1 reference

Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract

31 March 2020

1 reference

Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium

31 March 2020

1 reference

Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM

31 March 2020

1 reference

The enhancement of virus infectivity by antibody

31 March 2020

1 reference

Profiles of antibody-dependent enhancement of dengue virus type 2 infection

31 March 2020

1 reference

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

31 March 2020

1 reference

Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies

31 March 2020

1 reference

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody

31 March 2020

1 reference

Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis

31 March 2020

1 reference

Vaccination strategies for mucosal immune responses

31 March 2020

1 reference

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

31 March 2020

1 reference

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

31 March 2020

1 reference

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

31 March 2020

1 reference

Effector and memory T-cell differentiation: implications for vaccine development

31 March 2020

1 reference

Cellular immune responses to HIV.

31 March 2020

1 reference

CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses

31 March 2020

1 reference

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

31 March 2020

1 reference

Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR

31 March 2020

1 reference

The CD4(+) T cell response to HIV-1.

31 March 2020

1 reference

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

31 March 2020

1 reference

Immunity to retroviral infection: the Friend virus model

31 March 2020

1 reference

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection

31 March 2020

1 reference

Different immunological requirements for protection against acute versus persistent Friend retrovirus infections

31 March 2020

1 reference

Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity

31 March 2020

1 reference

Long-lived plasma cells: a mechanism for maintaining persistent antibody production.

31 March 2020

1 reference

Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs

31 March 2020

1 reference

The clinical use of gamma globulin

31 March 2020

1 reference

Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts

31 March 2020

1 reference

Heterologous protection against influenza by injection of DNA encoding a viral protein

31 March 2020

1 reference

Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge

31 March 2020

1 reference

Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine

31 March 2020

1 reference

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

31 March 2020

1 reference

Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication

31 March 2020

1 reference

The influence of virus structure on antibody responses and virus serotype formation

31 March 2020

1 reference

Neutralizing antiviral B cell responses

31 March 2020

1 reference

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

31 March 2020

1 reference

HIV-1 antibody--debris or virion?

31 March 2020

1 reference

Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?

31 March 2020

1 reference

Influenza: the new acquayantance

31 March 2020

1 reference

Predetermination by infection and by vaccination of antibody response to influenza virus vaccines

31 March 2020

1 reference

Disquisitions of Original Antigenic Sin. I. Evidence in man

31 March 2020

1 reference

Original antigenic sin: experiments with a defined antigen

31 March 2020

1 reference

Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection

31 March 2020

1 reference

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

7 January 2021

Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants

1 reference

7 January 2021

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

7 January 2021

Protection of nonimmune volunteers against rubella by intravenous administration of normal human gamma globulin.

1 reference

7 January 2021

Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus

1 reference

7 January 2021

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NRI891

1 reference

PubMed ID

12209139

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

12209139